Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Understanding contextual and practical factors to inform WHO recommendations on using chest imaging to monitor COVID-19 pulmonary sequelae: a qualitative study exploring stakeholders' perspective

G. Honein-AbouHaidar, C. Rizkallah, I. Bou Akl, GP. Morgano, T. Vrbová, E. van Deventer, M. Del Rosario Perez, EA. Akl

. 2024 ; 22 (1) : 67. [pub] 20240611

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013530

Grantová podpora
001 World Health Organization - International

BACKGROUND: A recommendation by the World Health Organization (WHO) was issued about the use of chest imaging to monitor pulmonary sequelae following recovery from COVID-19. This qualitative study aimed to explore the perspective of key stakeholders to understand their valuation of the outcome of the proposition, preferences for the modalities of chest imaging, acceptability, feasibility, impact on equity and practical considerations influencing the implementation of using chest imaging. METHODS: A qualitative descriptive design using in-depth interviews approach. Key stakeholders included adult patients who recovered from the acute illness of COVID-19, and providers caring for those patients. The Evidence to Decision (EtD) conceptual framework was used to guide data collection of contextual and practical factors related to monitoring using imaging. Data analysis was based on the framework thematic analysis approach. RESULTS: 33 respondents, including providers and patients, were recruited from 15 different countries. Participants highly valued the ability to monitor progression and resolution of long-term sequelae but recommended the avoidance of overuse of imaging. Their preferences for the imaging modalities were recorded along with pros and cons. Equity concerns were reported across countries (e.g., access to resources) and within countries (e.g., disadvantaged groups lacked access to insurance). Both providers and patients accepted the use of imaging, some patients were concerned about affordability of the test. Facilitators included post- recovery units and protocols. Barriers to feasibility included low number of specialists in some countries, access to imaging tests among elderly living in nursing homes, experience of poor coordination of care, emotional exhaustion, and transportation challenges driving to a monitoring site. CONCLUSION: We were able to demonstrate that there is a high value and acceptability using imaging but there were factors influencing feasibility, equity and some practical considerations associated with implementation. We had a few suggestions to be considered by the expert panel in the formulation of the guideline to facilitate its implementation such as using validated risk score predictive tools for lung complications to recommend the appropriate imaging modality and complementary pulmonary function test.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013530
003      
CZ-PrNML
005      
20240905133924.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12961-023-01088-1 $2 doi
035    __
$a (PubMed)38862978
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Honein-AbouHaidar, Gladys $u Hariri School of Nursing, American University of Beirut, Beirut, Lebanon
245    10
$a Understanding contextual and practical factors to inform WHO recommendations on using chest imaging to monitor COVID-19 pulmonary sequelae: a qualitative study exploring stakeholders' perspective / $c G. Honein-AbouHaidar, C. Rizkallah, I. Bou Akl, GP. Morgano, T. Vrbová, E. van Deventer, M. Del Rosario Perez, EA. Akl
520    9_
$a BACKGROUND: A recommendation by the World Health Organization (WHO) was issued about the use of chest imaging to monitor pulmonary sequelae following recovery from COVID-19. This qualitative study aimed to explore the perspective of key stakeholders to understand their valuation of the outcome of the proposition, preferences for the modalities of chest imaging, acceptability, feasibility, impact on equity and practical considerations influencing the implementation of using chest imaging. METHODS: A qualitative descriptive design using in-depth interviews approach. Key stakeholders included adult patients who recovered from the acute illness of COVID-19, and providers caring for those patients. The Evidence to Decision (EtD) conceptual framework was used to guide data collection of contextual and practical factors related to monitoring using imaging. Data analysis was based on the framework thematic analysis approach. RESULTS: 33 respondents, including providers and patients, were recruited from 15 different countries. Participants highly valued the ability to monitor progression and resolution of long-term sequelae but recommended the avoidance of overuse of imaging. Their preferences for the imaging modalities were recorded along with pros and cons. Equity concerns were reported across countries (e.g., access to resources) and within countries (e.g., disadvantaged groups lacked access to insurance). Both providers and patients accepted the use of imaging, some patients were concerned about affordability of the test. Facilitators included post- recovery units and protocols. Barriers to feasibility included low number of specialists in some countries, access to imaging tests among elderly living in nursing homes, experience of poor coordination of care, emotional exhaustion, and transportation challenges driving to a monitoring site. CONCLUSION: We were able to demonstrate that there is a high value and acceptability using imaging but there were factors influencing feasibility, equity and some practical considerations associated with implementation. We had a few suggestions to be considered by the expert panel in the formulation of the guideline to facilitate its implementation such as using validated risk score predictive tools for lung complications to recommend the appropriate imaging modality and complementary pulmonary function test.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $7 D000086382
650    12
$a kvalitativní výzkum $7 D036301
650    _2
$a mužské pohlaví $7 D008297
650    12
$a Světová zdravotnická organizace $7 D014944
650    _2
$a ženské pohlaví $7 D005260
650    12
$a SARS-CoV-2 $7 D000086402
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a účast zainteresovaných stran $7 D000073597
650    _2
$a senioři $7 D000368
650    _2
$a plíce $x diagnostické zobrazování $7 D008168
650    _2
$a zdravotnický personál $7 D006282
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rizkallah, Cynthia $u Hariri School of Nursing, American University of Beirut, Beirut, Lebanon
700    1_
$a Bou Akl, Imad $u Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
700    1_
$a Morgano, Gian Paolo $u Department of Health Research Methods, Evidence and Impact McMaster University, 1280 Main Street West, Hamilton, Canada
700    1_
$a Vrbová, Tereza $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (CEBHC-KT), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a van Deventer, Emilie $u Radiation and Health Unit, Department of Environment, Climate Change and Health, World Health Organization, Geneva, Switzerland. vandeventere@who.int
700    1_
$a Del Rosario Perez, Maria $u Radiation and Health Unit, Department of Environment, Climate Change and Health, World Health Organization, Geneva, Switzerland
700    1_
$a Akl, Elie A $u Department of Medicine, American University of Beirut, Riad-El-Solh, P.O. Box 11-0236, Beirut, 1107 2020, Lebanon. ea32@aub.edu.lb $1 https://orcid.org/0000000234448618
773    0_
$w MED00008226 $t Health research policy and systems $x 1478-4505 $g Roč. 22, č. 1 (2024), s. 67
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38862978 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133918 $b ABA008
999    __
$a ok $b bmc $g 2143379 $s 1225396
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 22 $c 1 $d 67 $e 20240611 $i 1478-4505 $m Health research policy and systems $n Health Res Policy Syst $x MED00008226
GRA    __
$a 001 $p World Health Organization $2 International
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...